Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-11-20
DOI
10.3389/fimmu.2018.02666
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effect of clinically relevant doses of immunosuppressive drugs on human mesenchymal stem cells
- (2018) Eliska Javorkova et al. BIOMEDICINE & PHARMACOTHERAPY
- Regulatory T Cells and Kidney Transplantation
- (2018) Paloma Leticia Martin-Moreno et al. Clinical Journal of the American Society of Nephrology
- Interspecies Incompatibilities Limit the Immunomodulatory Effect of Human Mesenchymal Stromal Cells in the Rat
- (2018) Paul Lohan et al. STEM CELLS
- Pathological conversion of regulatory T cells is associated with loss of allotolerance
- (2018) Jing Hua et al. Scientific Reports
- Regulatory T-cell therapy in liver transplantation
- (2017) Gavin P. Whitehouse et al. TRANSPLANT INTERNATIONAL
- Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease
- (2017) Samantha F. H. de Witte et al. Stem Cell Research & Therapy
- Anti-Donor Immune Responses Elicited by Allogeneic Mesenchymal Stem Cells and Their Extracellular Vesicles: Are We Still Learning?
- (2017) Paul Lohan et al. Frontiers in Immunology
- Endothelial keratoplasty versus repeat penetrating keratoplasty after failed penetrating keratoplasty: A systematic review and meta-analysis
- (2017) Feng Wang et al. PLoS One
- Mesenchymal stem cell therapy to promote corneal allograft survival
- (2016) Nick Murphy et al. Current Opinion in Organ Transplantation
- In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation
- (2016) Maryam Tahvildari et al. TRANSPLANTATION
- Prevention and Treatment of Corneal Graft Rejection
- (2015) Bhairavi Kharod-Dholakia et al. CORNEA
- Systemic immunosuppression with mycophenolate mofetil to prevent corneal graft rejection after high-risk penetrating keratoplasty: a 2-year follow-up study
- (2015) Jacek P. Szaflik et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Adipose-Derived Mesenchymal Stem Cell Administration Does Not Improve Corneal Graft Survival Outcome
- (2015) Sherezade Fuentes-Julián et al. PLoS One
- Mesenchymal stem/stromal cells precondition lung monocytes/macrophages to produce tolerance against allo- and autoimmunity in the eye
- (2015) Jung Hwa Ko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Foxp3-expressing sensitized Teff cells prolong survival of corneal allograft in corneal allograft transplantation mouse model
- (2015) Jun Zhao et al. TRANSPLANT IMMUNOLOGY
- Concise Review: Process Development Considerations for Cell Therapy
- (2015) Andrew Campbell et al. Stem Cells Translational Medicine
- Mesenchymal Stem Cell Therapy Promotes Corneal Allograft Survival in Rats by Local and Systemic Immunomodulation
- (2014) O. Treacy et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Levels of Foxp3 in Regulatory T Cells Reflect Their Functional Status in Transplantation
- (2014) S. K. Chauhan et al. JOURNAL OF IMMUNOLOGY
- Interferon-Gamma Modification of Mesenchymal Stem Cells: Implications of Autologous and Allogeneic Mesenchymal Stem Cell Therapy in Allotransplantation
- (2014) Kisha Nandini Sivanathan et al. Stem Cell Reviews and Reports
- Chondrogenic Differentiation Increases Antidonor Immune Response to Allogeneic Mesenchymal Stem Cell Transplantation
- (2013) Aideen E Ryan et al. MOLECULAR THERAPY
- The high-risk corneal regraft model: a justification for tissue matching in humans
- (2013) Andrea Vitova et al. TRANSPLANT INTERNATIONAL
- Role of Lentivirus-Mediated Overexpression of Programmed Death-Ligand 1 on Corneal Allograft Survival
- (2012) M. Nosov et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Immunomodulatory effects of mesenchymal stem cells in a rat corneal allograft rejection model
- (2012) Zhe Jia et al. EXPERIMENTAL EYE RESEARCH
- Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?
- (2012) Matthew D Griffin et al. IMMUNOLOGY AND CELL BIOLOGY
- Intravenous Mesenchymal Stem Cells Prevented Rejection of Allogeneic Corneal Transplants by Aborting the Early Inflammatory Response
- (2012) Joo Youn Oh et al. MOLECULAR THERAPY
- Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing
- (2011) Moïra François et al. CYTOTHERAPY
- Immunogenicity of allogeneic mesenchymal stem cells
- (2011) Sabine Schu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Bone Marrow-Derived Mesenchymal Stromal Cells Inhibit Th2-Mediated Allergic Airways Inflammation in Mice
- (2011) Meagan Goodwin et al. STEM CELLS
- Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model
- (2011) Elke Eggenhofer et al. TRANSPLANT IMMUNOLOGY
- Intravenous hMSCs Improve Myocardial Infarction in Mice because Cells Embolized in Lung Are Activated to Secrete the Anti-inflammatory Protein TSG-6
- (2009) Ryang Hwa Lee et al. Cell Stem Cell
- Adenoviral-Mediated Endothelial Precursor Cell Delivery of Soluble CD115 Suppresses Human Prostate Cancer Xenograft Growth in Mice
- (2009) Trevor Lucas et al. STEM CELLS
- Species Variation in the Mechanisms of Mesenchymal Stem Cell-Mediated Immunosuppression
- (2009) Guangwen Ren et al. STEM CELLS
- Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide
- (2008) Guangwen Ren et al. Cell Stem Cell
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started